This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Procedures and Follow-up of Percutaneous Tracheostomy in Intensive Care Unit

This study is currently recruiting participants.
See Contacts and Locations
Verified February 2016 by Paolo Pelosi, University of Genova
Information provided by (Responsible Party):
Paolo Pelosi, University of Genova Identifier:
First received: February 6, 2013
Last updated: February 2, 2016
Last verified: February 2016
Tracheostomy is worldwide performed in Intensive Care Unit (ICU). According to the current literature, indication for percutaneous tracheostomy (PDT) in ICU are: difficult prolonged weaning, prolonged mechanical ventilation, loss of airway reflex, copious secretions, upper airway obstruction. Many studies have focused on the comparison between different PDT techniques and complication. The aim of our study is to evaluate the procedural features, complications, ICU mortality, quality of life, post-discharge mortality of patients undergoing different PDT techniques performed in ICU.

Condition Intervention
Acute Respiratory Failure Neurological Disease Heart Failure Procedure: Percutaneous tracheostomy

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Procedures, Complications and Follow-up of Percutaneous Tracheostomies in Intensive Care Unit

Resource links provided by NLM:

Further study details as provided by Paolo Pelosi, University of Genova:

Primary Outcome Measures:
  • Safety of percutaneous tracheostomy [ Time Frame: at the beginning and at the end of the procedure ]

Secondary Outcome Measures:
  • Early complications [ Time Frame: in the first 24 hours from the end of the procedure ]
    Early complications are:multiple intubation attempts (more than 1), accidental extubation, paratracheal insertion, injuries to blood vessels in the neck, oesophageal injury, accidental decannulation, malposition of the tracheostomy tube, tracheal cuff puncture, multiple punctures (more than 1), surgical conversion and percutaneous tracheostomy failure, minor bleeding (compressible), major bleeding (incompressible), pneumothorax

  • Late complications [ Time Frame: from the 2nd day ofter the procedure until the ICU discharge (expected average of 2 weeks) ]
    Late complications are: minor bleeding (compressible), major bleeding (incompressible) tracheostomy puncture site infection, subglottic stenosis, fracture of a tracheal cartilage, granuloma.

  • Quality of life [ Time Frame: at 3, 6 and 12 months after tracheostomy ]
    The investigator will use the EURO-QOL

  • Evaluation of organ function [ Time Frame: At 3, 6 , and 12 months after tracheostomy ]
    The investigator will perform a flexible fiberoptic laryngoscopy.

  • Quality of voice [ Time Frame: At 3,6, 12 months after tracheostomy ]
    the investigator will use a KAY elemetrics analyzer.

  • Mortality [ Time Frame: at 3, 6 and 12 months from tracheostomy ]

Estimated Enrollment: 200
Study Start Date: June 2012
Estimated Study Completion Date: January 2017
Estimated Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
critical ill patients
The investigator will enroll all the critical ill patients undergoing percutaneous tracheostomy performed in ICU
Procedure: Percutaneous tracheostomy
Percutaneous tracheostomies will be performed with the kit commercially available in the current clinical practice.


Ages Eligible for Study:   18 Years to 82 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Criticall ill patients requiring percutaneous tracheostomy in intensive care unit

Inclusion Criteria:

  • age >18
  • indication for tracheostomy

Exclusion Criteria:

  • infectious disease of neck
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01792258

Contact: Paolo Pelosi, professor +39 010 5553136

University of Genoa Recruiting
Genoa, Italy, 16132
Contact: Paolo Pelosi, professor    +39 010 555 3136   
Principal Investigator: Paolo Pelosi, professor         
Sub-Investigator: Maria Vargas, MD         
Sub-Investigator: Iole Brunetti, md         
Sponsors and Collaborators
University of Genova
Principal Investigator: Paolo Pelosi University of Genoa
  More Information

Responsible Party: Paolo Pelosi, Professor, University of Genova Identifier: NCT01792258     History of Changes
Other Study ID Numbers: 53/12
Study First Received: February 6, 2013
Last Updated: February 2, 2016

Keywords provided by Paolo Pelosi, University of Genova:
Percutaneous tracheostomy
Intensive Care Unit
Ineffective Airway Clearance
Weaning failure

Additional relevant MeSH terms:
Heart Failure
Respiratory Insufficiency
Respiratory Distress Syndrome, Adult
Nervous System Diseases
Heart Diseases
Cardiovascular Diseases
Respiration Disorders
Respiratory Tract Diseases
Lung Diseases processed this record on September 19, 2017